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ABSTRACT
The prevalence of Dientamoeba fragilis in patients
from a metropolitan area in Denmark was
determined by examination of paired stool sam-
ples using two techniques: a formol ethyl-acetate
concentration technique with unpreserved faeces
and a permanent staining technique on faeces
preserved with sodium acetate–acetic acid–for-
malin (SAF). Using the SAF permanent staining
technique and the formol ethyl-acetate concentra-
tion technique, 25% and 15% of the specimens,
respectively, were parasite-positive. D. fragilis
was detected in 12 of the 103 patients, only two
of whom harboured other recognised pathogenic
parasites. Overall, D. fragilis had a remarkably
high prevalence in the metropolitan area of
Denmark investigated.
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Dientamoeba fragilis [1] is a non-invasive, single-
celled flagellate found in the colon that is
associated with various gastrointestinal symp-
toms [2–7]. Several detailed reviews concerning
this parasite have been published [8–10]. D. fragilis
has no recognised cyst stage. Diagnosis relies on
the detection of trophozoites in freshly passed,
warm stools, or in freshly passed stools that have
been preserved using fixatives, e.g., sodium
acetate–acetic acid–formalin (SAF) [11]. Few labo-
ratories in Europe test for D. fragilis on a routine
basis [12], and few prevalence estimates are
available, with those that do exist being difficult
to compare because of differences in study design
and populations. The present study was under-
taken to estimate the prevalence of D. fragilis in
Danish patients suspected of having intestinal
parasitosis, and to assess the diagnostic value of
analysing fixed or unfixed faecal specimens with
respect to the detection of protistan intestinal
parasites in a setting where instant examination
of freshly passed stools was not possible.
Patients, mainly from Amager (Copenhagen,
Denmark), who were suspected of having an
intestinal parasitosis, as assessed by their general
practitioners, were invited to participate in the
study. Participants submitted two samples from
the same stool; one sample was mixed thoroughly
with SAF (Para-Pak; Meridian Bioscience, New-
town, OH, USA), while the other remained
unpreserved. Following arrival at the laboratory,
0.5–1 g of unpreserved material was cultured in
Jones’ medium [13] and examined for Blastocystis.
The remainder of the sample was examined for
ova, cysts and larvae by a formol ethyl-acetate
concentration technique [14], and for oocysts of
sporozoa using a Ziehl–Neelsen technique [15].
The SAF-preserved sample was processed and
stained by Wheatley’s modified Gomori’s tri-
chrome staining procedure [16]. Examinations of
faecal concentrates, permanently stained smears
and faecal cultures were performed indepen-
dently by three different laboratory technicians.
Bacterial or viral analyses were not included
consistently in the study, but such results from
simultaneous analyses were available for 41 of 103
patients.
Patient demographical details included infor-
mation concerning gender, age and travel history
within the 3-month period before stool examina-
tion, and whether the patient had experienced
periods of diarrhoea, defined as three or more
loose stools daily at or shortly before the time of
examination.
Statistical analyses, including McNemar’s test
for paired observations and a non-parametric,
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two-sample Wilcoxon rank sum (Mann–Whitney)
test for comparing the age distribution among
groups, were performed using STATA 8.0 ⁄ SE
software (Stata Corp., College Station, TX, USA);
other comparisons were made by risk-ratio
analysis and Fisher’s exact test for small samples
data.
In total, 117 pairs of stool specimens were
received from 103 patients, 27 (26%) of whom
harboured one or more parasites after considering
the results of all diagnostic techniques. Overall, 29
(25%) and 18 (15%) stools were positive for one
or more parasites according to the permanent
staining test of SAF-preserved samples and the
formol ethyl-acetate concentration technique,
respectively (OR 18; 95% CI 4.4–infinity).
D. fragilis was detected in 14 specimens from 12
patients by the SAF permanent staining test
(Table 1), but was not detected in any of the
unpreserved specimens. D. fragilis was the only
parasite detected in four (33%) of 12 D. fragilis-
positive patients; Blastocystis was also seen in the
remaining eight (67%) patients, only two of
whom were positive for clinically recognised
pathogenic parasites (Giardia intestinalis and En-
tamoeba histolytica ⁄Entamoeba dispar). Ten patients
were diagnosed with multiple parasite species.
The age distribution of D. fragilis-positive
individuals compared to that of parasite-positive
and participating individuals in general is shown
in Fig. 1. The median age of parasite-positive and
parasite-negative patients was 26.5 years (inter-
quartile range (IQR) 2.25–38) and 27 years
(IQR 20–43), respectively (p 0.0475); the median
age of D. fragilis-positive and D. fragilis-negative,
parasite-positive patients was 20 years
(IQR 18.5–27) and 40 years (IQR 33–46), respec-
tively (p 0.0053).
Anamnestic details were available for 89 of 103
patients. Charcot Leyden crystals and parasites
other than D. fragilis were detected in 19 of 43
patients with a history of travel, compared to
eight of 46 patients with no history of travel
(relative risk (RR) 1.82, 95% CI 1.22–2.71, p 0.010;
Fisher’s exact test). Seven of 12 patients with
D. fragilis had a history of travel (RR 1.25,
95% CI 0.73–2.13; p 0.663; Fisher’s exact test). In
total, 69 (78%) patients had experienced three or
more loose stools daily at or shortly before the
time of faecal sampling. Seven of 12 patients with
D. fragilis in mono-infections and poly-infections
had diarrhoea, as did two of three patients
positive for D. fragilis but negative for Charcot
Leyden crystals, other parasites, bacteria and
viruses.
This is the first report concerning the occur-
rence of D. fragilis infections in Denmark. The
prevalence of D. fragilis in patients with suspected
enteroparasitic disease was six-fold higher than
that of Giardia, and higher than the prevalences
reported in Belgium [5] and Turkey [2]. Grendon
et al. [3] found that diarrhoea was the symptom
reported most frequently by D. fragilis-infected
patients, although other studies [3–6] have re-
ported that abdominal pain is the most common
symptom. In the present study, the patients were
asked only to provide information concerning the
presence or absence of diarrhoea. For cases in
which examinations for a variety of bacterial and
viral agents were undertaken, two of three
patients negative for bacteria, virus and all
parasites except D. fragilis reported diarrhoea.
Table 1. Intestinal parasites detec-
ted in paired faecal specimens
(n = 117) following permanent
staining of preserved faecal samples
(SAF-PST), the formol ethyl-acetate
concentration technique for unpre-
served faecal samples (FECT),
Ziehl–Neelsen staining for sporozoa,
and culture for Blastocystis
Species
No. of positive samples
SAF-PST FECT
Ziehl–Neelsen
staininga
Blastocystis
spp. cultureb
Cysts Trophozoitesc
Cysts and
trophozoites Cystsc Oocysts
Various
stages
Dientamoeba fragilis – 14 – – – –
Blastocystis spp. 0 23 0 15 – 25
Giardia intestinalis 4 0 0 4 – –
Entamoeba histolytica ⁄E. dispar 0 3 1 4 – –
Cryptosporidium spp. – – – – 1 –
Cyclospora cayetanensis – – – – 1 –
Endolimax nana 1 1 0 5 – –
Entamoeba coli 1 2 0 4 – –
Entamoeba hartmanni 0 1 0 0 – –
aZiehl–Neelsen staining performed on FECT concentrates.
bFour samples were not cultured; of these, one was positive by SAF-PST.
cIn the case of Blastocystis spp., the stages recognised using the SAF-PST and the FECT were mainly vacuolar
stages.
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However, it was not possible to establish an
association between the presence of the parasite
and diarrhoea because of the limited population
size and the design of the present study.
Day-to-day variation in the shedding of para-
sites is common, including in cases of D. fragilis
infection [7,17], which could lead to an under-
estimate of the prevalence of D. fragilis. Never-
theless, the data indicate that D. fragilis may be of
endemic occurrence in Denmark. Unlike other
parasites, the diagnosis of D. fragilis was not
associated with a history of foreign travel. Thus,
three of the four patients shown to harbour only
D. fragilis had no history of travel outside
Denmark during the 3-month period before stool
sampling, although D. fragilis infections may
admittedly persist for months or years [18].
Findings concerning the age distribution of
Dientamoeba-infected individuals should be inter-
preted with care, since the results may be
confounded by study design. However, the
present study indicated that D. fragilis-infected
patients were much younger than patients who
were positive for other parasites. The present
study also highlighted the importance of preser-
ving freshly passed stools when a delay in
parasitological examination is expected, since
D. fragilis was detected solely in SAF-fixed faeces,
and the detection rate of Blastocystis was also
markedly increased.
In conclusion, it appears that potentially
symptomatic, curable, intestinal parasitosis may
apparently go undetected by the formol
ethyl-acetate concentration technique in c. 80%
of patients suspected of having an intestinal
parasitosis, despite the examination of multiple
stool samples. If confirmed by larger studies, this
will have important consequences for routine
diagnosis of intestinal parasites and may nece-
ssitate a revision of standard parasitological
procedures. Finally, D. fragilis infections seem to
be of endemic occurrence in Denmark, a highly
developed and industrialised country that has
very few cases of parasite-related outbreaks and
in which hygiene standards are believed to be
excellent.
ACKNOWLEDGEMENTS
The authors thank M. Yamakawa, L. Wismer, D. S. Moradi,
J. Niss, M. Lebbad, M. Midgely, K. E. P. Olsen and B. Bo¨ttiger
for providing help and assistance in various ways.
REFERENCES
1. Jepps MW, Dobell C. Dientamoeba fragilis, n.g., n.sp., a new
intestinal amoeba from man. Parasitology 1918; 10: 352–367.
2. Girginkardesler N, Coskun S, Cu¨neyt Balcıog˘lu _I, Ertan P,
Ok U¨. Dientamoeba fragilis, a neglected cause of diarrhea,
successfully treated with secnidazole. Clin Microbiol Infect
2003; 9: 110–113.
0
5
10
15
20
25
30
0–5 6–10 11–15 16–20 21–25 26–30 31–35 36–40 41–45 46–50 51–55 56–60 60–65 66–70 71–75
Age group (years)
N
o.
 o
f p
at
ie
nt
s
Participating patients
Parasite-positive patients
D. fragilis-positive patients
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